Heterocyclic derivatives as metabotropic glutamate receptor modulators
申请人:Merz Pharma GmbH & Co. KGaA
公开号:EP2650284A1
公开(公告)日:2013-10-16
The invention relates to heterocyclic derivatives of formula I as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.